A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
Sponsor: MEI Pharma, Inc.
This PHASE2 trial investigates Prostate Cancer and is currently completed. MEI Pharma, Inc. leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MEI Pharma, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .